04.10.2014 Views

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

Competition in the Irish Private Health Insurance Market

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

4.74 The Authority had a specific statutory role to advise <strong>the</strong> M<strong>in</strong>ister <strong>in</strong><br />

relation to <strong>the</strong> <strong>in</strong>troduction of risk equalisation payments on foot of any<br />

risk equalisation scheme made by <strong>the</strong> M<strong>in</strong>ister.<br />

4.75 As noted above, under <strong>the</strong> Act, <strong>the</strong> Authority has a specific<br />

responsibility with regard to risk equalisation and to advise <strong>the</strong> M<strong>in</strong>ister<br />

on matters relat<strong>in</strong>g to <strong>the</strong> functions of <strong>the</strong> M<strong>in</strong>ister or <strong>the</strong> Authority and<br />

health <strong>in</strong>surance generally. On 19th February 2002, <strong>the</strong> Authority<br />

published a Consultation Paper on Risk Equalisation <strong>in</strong> <strong>the</strong> <strong>Private</strong><br />

<strong>Health</strong> <strong>Insurance</strong> <strong>Market</strong> <strong>in</strong> Ireland. There was a wide rang<strong>in</strong>g<br />

consultation process conducted <strong>in</strong> order to seek representations on<br />

issues relat<strong>in</strong>g to risk equalisation from stakeholders and <strong>in</strong>terested<br />

parties <strong>in</strong> <strong>the</strong> private health <strong>in</strong>surance market <strong>in</strong> Ireland and, <strong>in</strong><br />

particular, to seek views as to how <strong>the</strong> Authority should exercise its<br />

powers and duties <strong>in</strong> relation to risk equalisation.<br />

4.76 Hav<strong>in</strong>g considered <strong>the</strong> submissions made, <strong>the</strong> Authority published a<br />

Policy Paper on Risk Equalisation <strong>in</strong> <strong>the</strong> <strong>Private</strong> <strong>Health</strong> <strong>Insurance</strong><br />

<strong>Market</strong> <strong>in</strong> Ireland <strong>in</strong> September 2002. In that Policy Paper, <strong>the</strong><br />

Authority set out its prelim<strong>in</strong>ary views with regard to <strong>the</strong><br />

appropriateness of commenc<strong>in</strong>g risk equalisation payments and<br />

identified a number of factors that it would consider when consider<strong>in</strong>g<br />

whe<strong>the</strong>r or not risk equalisation payments should be commenced <strong>in</strong> <strong>the</strong><br />

best overall <strong>in</strong>terests of health <strong>in</strong>surance consumers.<br />

4.77 The European Commission delivered its State Aid verdict <strong>in</strong> 2003<br />

conclud<strong>in</strong>g that “<strong>the</strong> Risk Equalisation Scheme is necessary to underp<strong>in</strong><br />

<strong>the</strong> pr<strong>in</strong>ciples enforced by <strong>the</strong> <strong>Irish</strong> authorities.... it ensures that risks<br />

are shared appropriately across <strong>the</strong> market and allows for a level<br />

play<strong>in</strong>g field <strong>in</strong> respect of <strong>the</strong> particular constra<strong>in</strong>ts of <strong>the</strong> <strong>Irish</strong> system.<br />

If, as an alternative, <strong>the</strong> <strong>Irish</strong> PMI market was risk rated, <strong>the</strong> Risk<br />

Equalisation Scheme would not be necessary.” It concluded that <strong>the</strong><br />

scheme passed both <strong>the</strong> necessity and <strong>the</strong> proportionality test.<br />

4.78 Most articles of <strong>the</strong> Risk Equalisation Scheme 2003 (<strong>the</strong> “Scheme”)<br />

came <strong>in</strong>to operation on 1 July 2003 and <strong>in</strong> July 2003, <strong>the</strong> Authority<br />

published a Guide to <strong>the</strong> Scheme 2003. That document set out <strong>the</strong><br />

regulatory structure of <strong>the</strong> <strong>Irish</strong> private health <strong>in</strong>surance market, <strong>the</strong><br />

role of <strong>the</strong> Authority, its views as to why risk equalisation payments<br />

might be required and how risk equalisation calculations would operate<br />

<strong>in</strong> practice.<br />

4.79 In July 2003 <strong>the</strong> Authority commissioned York <strong>Health</strong> Economics<br />

Consortium (a firm of consultants specialis<strong>in</strong>g <strong>in</strong> <strong>the</strong> area of health<br />

economics) <strong>in</strong> conjunction with <strong>the</strong> Office of <strong>Health</strong> Economics <strong>in</strong> <strong>the</strong><br />

UK (“York”) to undertake an <strong>in</strong>dependent review of <strong>the</strong><br />

competitiveness of <strong>the</strong> private health <strong>in</strong>surance market <strong>in</strong> Ireland.<br />

4.80 In November 2003, York presented its report entitled “Assessment of<br />

Risk Equalisation and <strong>Competition</strong> <strong>in</strong> <strong>the</strong> <strong>Irish</strong> <strong>Health</strong> <strong>Insurance</strong><br />

<strong>Market</strong>” to <strong>the</strong> Authority. The overall conclusions reached by York from<br />

its study of <strong>the</strong> private health <strong>in</strong>surance market and <strong>the</strong> competitive<br />

forces <strong>in</strong> that market were (as set out at page 97 of <strong>the</strong> report):<br />

−<br />

Risk equalisation is one of several factors which are deterr<strong>in</strong>g<br />

potential entrants to <strong>the</strong> <strong>Irish</strong> health <strong>in</strong>surance market;<br />

65

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!